Ondansetron

Product NDC: 50090-1659
Requested package NDC: 50090-1659-0
11-digit product format: 500901659
Labeler code: 50090
Product ID: 50090-1659_b78afa5d-da9c-4dbb-8509-857dc2b89dd0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ondansetron
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA078152
Marketing category: ANDA
Marketing start: 2007-06-27
Substance: ONDANSETRON
Active strength: 4 mg/1
Pharmacologic classes: Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078152-001	ONDANSETRON	ONDANSETRON	4MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB		2007-06-27
A078152-002	ONDANSETRON	ONDANSETRON	8MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB		2007-06-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A078152-001	AB
A078152-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A078152-001	ONDANSETRON	4MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB		2007-06-27	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A078152-002	ONDANSETRON	8MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB		2007-06-27	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A078152-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A078152-002	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 2 · 25 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ondansetron	ONDANSETRON	A-S Medication Solutions	5a81a39b-051b-414e-a6b0-d844de4e9ab4	2026-07-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	A-S Medication Solutions	02ddd5f5-76d3-4f1c-9af3-d39e05a19c29	2026-07-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152 ndc (package): 50090-1659-0 ndc (product): 50090-1659 ndc11 (package): 50090165900
Ondansetron	ONDANSETRON	REMEDYREPACK INC.	9c3ad9c1-474e-4331-a017-09cec46702d8	2026-07-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals,Inc	4575d288-be0c-f6c3-e063-6294a90af708	2026-06-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Cardinal Health 107, LLC	3c34ca82-9705-4784-be7c-8b50351d14fc	2026-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Preferred Pharmaceuticals Inc.	e87a5803-e872-43f7-8a15-79aa236e8c07	2026-06-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	BluePoint Laboratories	ed1132ec-c2cd-4646-b69d-26663bb937a4	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	REMEDYREPACK INC.	c0d827d0-333f-4187-ac75-9dc7d34b6169	2026-05-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals,Inc.	5bacb621-1261-25d9-e053-2991aa0afa3b	2026-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals,Inc.	df736abd-9cec-4e90-e053-2995a90aab5e	2026-03-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals, Inc.	50383ef5-6e6e-63a7-e054-00144ff88e88	2026-03-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals,Inc.	ef6ce203-4ae3-19c9-e053-2995a90af796	2026-02-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	ST. MARY'S MEDICAL PARK PHARMACY	41366a20-0727-0446-e063-6294a90a957f	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	PD-Rx Pharmaceuticals, Inc.	d117de5f-64e5-464c-b782-de0f07e66c8e	2026-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Glenmark Pharmaceuticals Inc., USA	eee5217a-eba8-463a-812d-bf3c66f0934f	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Northwind Health Company, LLC	f29f5cfa-3cc4-7d53-e053-2995a90ae844	2025-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	ST. MARY'S MEDICAL PARK PHARMACY	f175a336-433b-7ab2-e053-2995a90ad5ca	2025-12-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	AvKARE	352de988-d166-c2d8-e063-6294a90acc01	2025-11-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Proficient Rx LP	81366c85-c6c9-4a9a-9fe5-cdd8c2d19f74	2025-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152
Ondansetron	ONDANSETRON	Preferred Pharmaceuticals Inc.	7975d78c-9bb6-467a-9c2d-ea15bde7af5c	2025-09-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078152 application number: ANDA078152

Additional Listing Data#

Finished product: Yes
Brand name base: Ondansetron
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ONDANSETRON	4 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4AF302ESOS	Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
02ddd5f5-76d3-4f1c-9af3-d39e05a19c29	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d9bd4853-037c-6968-f4d4-9bb9a0efd1ea	Product name	2	20250722
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
32e23bc9-ce14-4555-bb6d-bcb654d7d296	Product name	1	20201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49	Product name	1	20201015
909480fe-0d18-c1c1-a658-0bd9a7131822	Product name	5	20170829
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-1659-0	2023-10-23	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991
50090-1659-0	2023-10-23	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991
50090-1659-0	2023-10-23	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991
50090-1659-0	2023-01-30	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991
50090-1659-0	2023-01-30	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991
50090-1659-0	2023-01-30	C162847	48780-1	f386c64a-394c-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-1659-0	Ondansetron	10 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	10		13
50090-1659-0	Ondansetron	1 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	1		13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-1659-0	EA - Each	50090-1659	0c900953-bac3-4acc-abfa-d98394e65466	1	2018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-1659	ONDANSETRON TABLET, ORALLY DISINTEGRATING [A-S MEDICATION SOLUTIONS]	11	Current NDC, Legacy NDC, 2 package rows	20231024_02ddd5f5-76d3-4f1c-9af3-d39e05a19c29.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4AF302ESOS	ONDANSETRON	99614-02-5	ONDANSETRON

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
104894	ondansetron 4 MG Disintegrating Oral Tablet	PSN	02ddd5f5-76d3-4f1c-9af3-d39e05a19c29	13
104894	ondansetron 4 MG Disintegrating Oral Tablet	SCD	02ddd5f5-76d3-4f1c-9af3-d39e05a19c29	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-1659-0	50090165900	1 BLISTER PACK in 1 CARTON (50090-1659-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK	1 blister pack	2015-01-23	0000-00-00	No	No	Current